38 related articles for article (PubMed ID: 38764818)
1. Clinical efficacy of different androgen deprivation therapies for prostate cancer and evaluation based on dynamic-contrast enhanced magnetic resonance imaging.
Guo W; Li M
Acta Biochim Pol; 2024; 71():12473. PubMed ID: 38812492
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.
Arevalo-Perez J; Trang A; Yllera-Contreras E; Yildirim O; Saha A; Young R; Lyo J; Peck KK; Holodny AI
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791921
[No Abstract] [Full Text] [Related]
3. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis.
Mu RQ; Lv JW; Ma CY; Ma XH; Xing D; Ma HS
World J Gastrointest Oncol; 2024 May; 16(5):1796-1807. PubMed ID: 38764818
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in rectal cancer and its correlation with tumor differentiation.
Shen FU; Lu J; Chen L; Wang Z; Chen Y
Mol Clin Oncol; 2016 Apr; 4(4):500-506. PubMed ID: 27073650
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.
Surov A; Kim JY; Aiello M; Huang W; Yankeelov TE; Wienke A; Pech M
In Vivo; 2022; 36(1):398-408. PubMed ID: 34972741
[TBL] [Abstract][Full Text] [Related]
8. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Jeck W; Johung KL; Kirilcuk N; Krishnamurthi S; Maratt JK; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Gregory K; Gurski L
J Natl Compr Canc Netw; 2022 Oct; 20(10):1139-1167. PubMed ID: 36240850
[TBL] [Abstract][Full Text] [Related]
9. DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer.
Li Z; Huang H; Wang C; Zhao Z; Ma W; Wang D; Mao H; Liu F; Yang Y; Pan W; Lu Z
Front Oncol; 2022; 12():881341. PubMed ID: 36106114
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
Sun D; Wu X; Wang L; Li G; Huang J; Li Y
Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
[TBL] [Abstract][Full Text] [Related]
11. The importance of MRI for rectal cancer evaluation.
Fernandes MC; Gollub MJ; Brown G
Surg Oncol; 2022 Aug; 43():101739. PubMed ID: 35339339
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient Ktrans in lung cancer.
Weber JD; Spiro JE; Scheffler M; Wolf J; Nogova L; Tittgemeyer M; Maintz D; Laue H; Persigehl T
PLoS One; 2022; 17(3):e0265056. PubMed ID: 35259199
[TBL] [Abstract][Full Text] [Related]
13. MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response.
Bates DDB; Homsi ME; Chang KJ; Lalwani N; Horvat N; Sheedy SP
Clin Colorectal Cancer; 2022 Mar; 21(1):10-18. PubMed ID: 34895835
[TBL] [Abstract][Full Text] [Related]
14. How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO).
Mazzeo E; Triggiani L; Frassinelli L; Guarneri A; Bartoncini S; Antognoni P; Gottardo S; Greco D; Borghesi S; Nanni S; Bruni A; Ingrosso G; D'Angelillo RM; Detti B; Francolini G; Magli A; Guerini AE; Arcangeli S; Spiazzi L; Ricardi U; Lohr F; Magrini SM
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070797
[TBL] [Abstract][Full Text] [Related]
15. Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer.
Fusco R; Granata V; Sansone M; Rega D; Delrio P; Tatangelo F; Romano C; Avallone A; Pupo D; Giordano M; Grassi R; Ravo V; Pecori B; Petrillo A
Radiol Med; 2021 Aug; 126(8):1044-1054. PubMed ID: 34041663
[TBL] [Abstract][Full Text] [Related]
16. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
17. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
Cao W; Chen HD; Yu YW; Li N; Chen WQ
Chin Med J (Engl); 2021 Mar; 134(7):783-791. PubMed ID: 33734139
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
